chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the pain under the bottom of my left foot like fire that would not go out, that pain was so unbearable; I could not walk, the bottom of foot was swollen; I could not walk, the bottom of foot was swollen; Weakness; My mind went blank I couldn't remember something I do all the time I just went blank; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration in deltoid right on 24May202 (Batch/Lot Number: EW0187; Expiration Date: unknown) (at the age of 48-year-old) as single dose for covid-19 immunisation. Medical history included covid-19 from an unknown date in the year 2020 to an unknown date in the year 2020. The patient's concomitant medications were not reported. The patient reported that she got the vaccine on the 24May2021 (Monday), by the 24May2021 (Monday night) "i had the pain under the bottom of my left foot like fire that would not go out, that pain was so unbearable" and that was the very same pain she had when she got the COVID the last year (2020), she had to be on round the clock medicine she could not walk, the bottom of foot was swollen just like she had the COVID last year, and there was a weakness. When I called to the doctor, the pain she was in, the doctor wanted her to go to the emergency room but she could not go to the emergency room it was so bad. When there was the weakness, she was so weak she just felt better this past Sunday (30May2021), that's how many stage it took me to come back to herself. The patient reported when the very day she got the vaccine she was at work and my mind went blank I couldn't remember something I do all the time I just went blank" and I could not remember. It was just that one shot to space the time and she was struggling couple of days after there was some struggle just remembering things all of that scary enough, but it was very concerning to the point where I could not want to take the second vaccine, that's how scary the whole experience for her. The outcome of the events was unknown.  Was requested for additional information
This case was reported by a healthcare professional (nurse) and described the occurrence of injection site redness in a 18-month-old male subject who was vaccinated with INFANRIX (GlaxoSmithKline). Concurrent vaccination included seasonal influenza vaccine (non-gsk); Sanofi; unknown; unknown given on 17 October 2012. On 17 October 2012 at 16:15 the subject received the 4th dose of INFANRIX (.5 ml, unknown route, left arm). On 18 October 2012, 1 day after vaccination with INFANRIX, the subject experienced injection site redness (8 centimeters x 6 centimeters) and injection site tenderness. On 19 October, 2 days after vaccination with INFANRIX, the subject experienced fever and inner ear infection. At the time of reporting, it was unknown if the immunization series was delayed or discontinued. At the time of reporting the events were unresolved. The healthcare professional considered the events of injection site redness and tenderness were probably related to vaccination with INFANRIX. The healthcare professional considered the fever was possibly related to vaccination with INFANRIX. The healthcare professional considered the inner ear infection to be unrelated to vaccination with INFANRIX. Follow up was received from healthcare professional (nurse) on 6 November 2012. The diagnosis was reported as a local reaction. The healthcare professional reported that the earliest sign or symptom of the events of injection site redness, injection site tenderness, fever, inner ear infection was on 17 October 2012. All events resolved on 19 October 2012. The nurse did not consider the events to be serious. The nurse noted that the immunization series was not delayed or discontinued. It was unknown if symptoms recurred following subsequent administration since the subject had not received the next dose. The reporter stated that the subject had not experienced any adverse events following previous vaccinations. This case has been reported to a Regulatory Agency with reference number 7645703.
Patient present to the pharmacy with right arm that is red , swollen and hot to touch. Pt noticed this morning around 7:30 AM and applied some hydrocortisone 1 %. Advised to take benadryl 25 mg every 6 hours and applying cold compress to alleviate the rash
she has one nodule; Intramammary lymph node enlargement; This is a spontaneous report received from a contactable nurse (patient) via a Pfizer.   A 58-year-old female patient received second dose of dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot Number: Unknown) via an unspecified route of administration on 14Apr2021 as DOSE 2, SINGLE for COVID-19 immunization. Medical history included osteoporosis, autoimmune disorder and osteopenia (she will be getting her Reclast infusion for her osteoporosis and osteopenia). The patient's concomitant medications were not reported. On an unspecified date in 2021, the patient experienced one nodule and intramammary lymph node enlargement. It was reported that she specified that she had one nodule and breast nodule. Patient stated that she received the last dose of Pfizer Covid-19 vaccine on 14Apr2021 and will get the booster dose in December. She had autoimmune disease, Osteoporosis and will be having treatment/taking medication for her Osteoporosis on 27Oct2021. She asked that taking the medication will affect the booster dose and does she need to take the booster dose before or after the treatment. She waited to get her mammogram on 27Jul2021, and it was normal. The sonogram she had the same day was abnormal and showed 2 nodules in her breast. She waited for two months and repeated the sonogram on 27Sep2021, and the 2 nodules were still there. The doctor stated it was Intramammary lymph node enlargement. The outcome of events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Information has been received from a registered nurse concerning a female (age not reported) who on an unspecified date was vaccinated with a dose of Gardasil (lot number not reported). The nurse reported that the patient, after receiving the Gardasil, did not received her next expected period. The patient sought unspecified medical attention. At the time of this report. the outcome was unknown. Additional information has been requested.
Sore arm; body aches; head ache; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Sep2022 as dose 4 (booster), single (Lot number: FPY137) at the age of 47 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 3, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 1, manufacturer unknown), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 14Sep2022, outcome "recovered" (Sep2022), described as "Sore arm"; PAIN (non-serious) with onset 14Sep2022, outcome "recovered" (Sep2022), described as "body aches"; CHILLS (non-serious) with onset 14Sep2022, outcome "recovered" (Sep2022); HEADACHE (non-serious) with onset 14Sep2022, outcome "recovered" (Sep2022), described as "head ache". Therapeutic measures were not taken as a result of pain in extremity, pain, headache, chills.  Additional information: The events were reported as non serious by the reporter. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. The facility where the most recent COVID-19 vaccine was administered was Pharmacy/Drug Store.
Approximately 24 hours after vaccine given, parent noted red area on arm at injection site.  Redness continued to increase in size, area becoming tender to touch, painful and itchy.  Child started on KEFLEX TID po.
After receiving the Covid vaccines in Spring 21,  I started experiencing late onset alopecia areata,  I have never had this in the past.  I experienced approx 30% hair loss.  8 weeks after receiving the booster (Pfizer) I went through profuse shedding for approx 4 months which has resulted in a diagnosis of Alopecia universalis.  I have no hair anywhere on my body, including in my nose.
Nausea; Vomiting; Sore arm; This is a spontaneous report from a contactable reporter(Consumer or other non HCP).  A 5-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in left arm, administration date 03Dec2021 at 16:15 (Lot number: FK5127) at the age of 5 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19: Yes. Concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: FK5127, Route of administration: Intramuscular; Anatomical site: Left arm; Administration time: 16:00), administration date: 11Nov2021, when the patient was 5 years old, for COVID-19 immunisation.  The following information was reported: NAUSEA (non-serious) with onset 04Dec2021 at 04:30, outcome "recovering", described as "Nausea"; VOMITING (non-serious) with onset 04Dec2021 at 04:30, outcome "recovering", described as "Vomiting"; PAIN IN EXTREMITY (non-serious) with onset 04Dec2021 at 04:30, outcome "recovering", described as "Sore arm". Therapeutic measures were not taken as a result of nausea, vomiting and pain in extremity.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.
Case number PHEH2016US021231, is an initial spontaneous report received from a pharmacist on 12 Aug 2016. This report refers to a male patient of an unknown age. Past medical history and concomitant medications were not reported. The patient was vaccinated with influenza vaccine (unknown whether seasonal or pandemic, batch number: not reported) on an unknown date. The patient also vaccinated with ZOSTAVAX Vaccine (other manufacture, batch number: not reported) on an unknown date. The pharmacist stated that, the patient was vaccinated with unspecified flu vaccine years ago and was diagnosed with Guillain Barre syndrome after receiving the vaccine (10 to 20 years ago). Reported that AFLURIA as the vaccine given was not ruled out. The outcome of the event was reported as complete recovery on an unknown date. The seriousness and causality of the event was not reported. The seriousness assessment of the event Guillain Barre syndrome was upgraded to medically significant based on the Novartis Important Medical Event list. Follow up report received from a pharmacist on 17 Oct 2016: Added suspect product (ZOSTAVAX Vaccine) and updated reporter comments.
This spontaneous reprot as received from a health care worker refers to an unspecified number of patiens of unknown age. On an unknown date in between 02-JUL-2015 and 04-AUG-2015, the unspecified number of patients were vaccinated with improperly stored GARDASIL (lot # K007828 and expiry date: 02-MAR-2017). No adverse effects were reported. This is one of the two reports from the same reporter. Additional information has been requested.
late reaction to the vaccine; deep sweating; very strong muscle pain; chills; tiredness; vomiting; headache; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION, HYPERHIDROSIS, (deep sweating), MYALGIA (very strong muscle pain), CHILLS (chills) and FATIGUE (tiredness) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. not provided) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], PENTOXIFYLLINE (TRENTAL) and HYDROCHLOROTHIAZIDE, IRBESARTAN (IRBESARTAN AND HYDROCHLOROTHIAZIDE) for an unknown indication.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 07-May-2021, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (late reaction to the vaccine), HYPERHIDROSIS (deep sweating), MYALGIA (very strong muscle pain), CHILLS (chills), FATIGUE (tiredness), VOMITING (vomiting) and HEADACHE (headache). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (rate reaction to the vaccine), HYPERHIDROSIS (deep sweating), MYALGIA (very strong muscle pain), CHILLS (chills), FATIGUE (tiredness), VOMITING (vomiting) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: normal (normal) normal. On an unknown date, Full blood count: normal (normal) normal.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include vintiasen 360.
Patient presented to the ER with complaints of progressively worsening SOB with cough and phlegm. D-dimer slightly elevated at 0.53. O2 sat 92%, tested positive for Covid-19. Patient was admitted.  Reactive airway disease primarily due to Covid-19. Patient required supplemental oxygen so Decadron IV was started. Patient was able to wean off oxygen without dypsnea or hypoxia. Patient received antibiotics for possible bacterial pneumonia. Patient was discharged home on steroids, pepcid and vitamin supplements.
Patient reports having a headache since the day of the vaccine on 8/11 and reports has not resolved.  Reported that on 8/17 she received her IV iron infusion and on 8/19 she experienced severe abdominal cramping which was a 10 on the pain scale, light headed ness,  a large quantity of coffee ground looking bowel movements, and was very weak.  She noted that she usually feels much better after her iron infusions and she was feeling well and had increased energy on the day after the iron infusion on 8/18, but the symptoms above started on 8/19.
This was my 2nd dose of the Pfizer vaccine.  My first dose was on 10/19/2021 and I just submitted a VAERS report for that dose as well, however I think I entered the date as 10/26 on the form (confirmation # Temporary VAERS: 709880).   After the first dose I began experiencing menstral bleeding within 24 hours (my most recent cycle ended 3 days prior to dose 1).  The bleeding continued for at least 48 hours.  Today, a little more than 48 hours after my 2nd dose, I began to bleed again.  I am reporting both instances because this is a very serious side effect that no one is talking about or acknowledging.  I have reporting both situations to my doctor and they are time stamped so that there is no question about the validity of my claims.  I have also recorded the bleeding dates in my personal mestral cycle tracker.  This is very concerning as I am still in my child bearing years.    I am requesting for my doctor to provide me with an exemption from any future required boosters.
Rash, swelling of arm and armpit, pain when lifting arm(4/30/2021-5/3/2021), fever(5/1/2021), severe fatigue(5/1/2021-5/3/2021). Unable to return to work on  5/3/2021 (rural mail carrier). Took OTC medicine and sleep. Slowly improving. Scheduled to return to work on 5/6/2021.
upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: TCR received on 16-07-2021 contain adverse event.
Muscle aches, headache, chills, nausea, diarrhea, chills, right arm pain, severe right armpit swelling (lymph node swelling).
Injection date: 05/03/21 Reaction date: 05/03/21 LOT: EW0161 EXP: 07/31/2021 Headache starting 2 hours post injection. Hx of migraines. Severe HA with fevers and chills starting approx. 12 hours post injection and lasting only 8-12 hours. Followed up with patient 05/18/21 and she states she still has this persistent headache that started 2 hours post injection.
having burning sensation and smoke smell 3-4 days after vaccine, with some intermittent brief chest pain and trouble breathing
Rec'd vaccine on 11/13/07. On 11/14/07 began with (L) upper arm tenderness. On 11/15/07 seen in office, significant tenderness with about 2 1/2" area of erythema/warmth, painful to move arm - treated with Keflex with improvement.
Swollen, tender, red, hot, itchy bump at injection site that grew to 4 inch diameter in 24 hours.
Head ache sore arm for about a day; Head ache sore arm for about a day; This is a spontaneous report from a non-contactable consumer (patient) or other non-health care professional. A 67-year-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 20Feb2021 (at the age of 67-year-old) as dose 2, single for covid-19 immunization. Medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing. Patient had no allergies to medications, food, or other products. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration, administered on 30Jan2021 as dose 1 single for COVID-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had been not tested for COVID-19 since the vaccination. On 20Feb2021 the patient experienced head ache sore arm for about a day. No treatment received for the events. Outcome of the events resolved on an unspecified date in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
About a month ago I started having weird episodes where my blood pressure goes up and facial flushing.  It doesn't happen every evening, but most evenings.  My doctor is running test such as urine test.  Right now, that is all that has been done.
Dizziness, NauseaVomiting, hot/cold flashes Narrative:
Around injection site, large red swollen area...itching and small blisters...tingling in fingers.
Shingles valacyclovir uveitis prednisone eye drops swollen lymph nodes
I felt fine that day and waking up the next. Then as I moved around, I started to feel uneasy. I vomited forcefully several times. My neck and upper back became stiff and painful. Then came chills, shaking, and more nausea. My throat felt like there was a lump in it that was closing me off. I  felt very weak and easily fatigued. I started to have visual issues, confusion, and was unable to focus. Neck pain continued to be severe. The next morning I woke feeling good, but within 2 hour again I went downhill. Symptoms are only about half as bad as the day before. Very very tired.
My son complained of leg pain, about an hour later he could no longer stand up on his own.  At about 2:00 AM he woke up screaming that his legs hurt and could no longer walk.  We rushed to hospital.  He was diagnosed with synovitis, fluid in his hip joints. He is still recovering.
Received flu vax 12/2/14 on 12/5/14 noted a severe stiffness in joints - hips and knees. Lasted until December 21, then subsided.
After my 2nd Covid-19 vaccine, which was by Pfizer, tinnitus suddenly made an appearance in my life upon awakening the next morning.  I didn't want to automatically link the tinnitus to the vaccine as a definite adverse effect because I believe in vaccines, and I realize that sometimes these things can be mere coincidence.  So, I went ahead and got my Moderna booster, which was my 3rd COVID vaccine. Unfortunately, the tinnitus worsened by the morning after this. So, I'm pretty much convinced now that there was an actual cause-and-effect relationship between the vaccines and my tinnitus.   Called me today and recommended I make a report on both of the two vaccines that led to the tinnitus and the worsening thereof, so here I am making my report.
This spontaneous report was received from a physician via a company representative referring to a female patient of unknown age. The patient's pertinent medical history, drug reactions, and allergies were not reported. Concomitant medications included multiple unspecified medications for pain and hypertension. On an unknown date (reported as "a couple of years ago"), the patient was vaccinated with a dose of ZOSTAVAX (Lot # and expiration date unspecified) for prophylaxis. The physician reported that the patient was experiencing pain "around her eye" and was seen at an unspecified emergency room in August 2016(reported as "about 6 months ago"), the patient also had "some neurological symptoms and a dilated pupil that resolved" on an unspecified date. Additionally, it was stated that "a physician scraped the tissue around the eye and the tissue came back positive for shingles". The patient received an unspecified treatment for the event. At the reporting time the patient present status was reported as recovered. The reporter did not assess the relationship between the event and ZOSTAVAX. Upon internal review the event of ophthalmic herpes zoster was determined to be medically significant. Additional information has been requested.
This spontaneous report was received from a healthcare professional concerning a 1 year old female patient with speech delay, mentally delayed and with no drug reaction/allergies. On 12-DEC-2012, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (dose, dose number, lot number, expiration date and route were not reported) for routine. No concomitant therapies were used by the patient at the time of the event. The healthcare worker reported that she was informed by a mother the patient, that patient developed a sensitivity to eating eggs after receiving (Oka/Merck) VARIVAX, since an unknown date. The healthcare worker reported that before receiving the (Oka/Merck) VARIVAX, the child was able to eat eggs fine but after receiving the (Oka/Merck) VARIVAX, patient got stomach pain after she ate eggs. The healthcare worker reported that an allergy lab panel was performed on 11-SEP-2014 (reported as about week ago), on the child and the result of the panel states that the child was not allergic to eggs. At the time of the report the outcome was reported as not recovered. Patient sought medical attention on approximately on 11-SEP-2014 (reported as a week ago). Patient did not received treatment for the adverse event. Additional information has been requested.